Is mammography adequate for screening women with inherited BRCA mutations and low breast density?

被引:25
作者
Bigenwald, Rachel Z. [1 ]
Warner, Ellen [1 ]
Gunasekara, Anoma [2 ]
Hill, Kimberley A. [1 ]
Causer, Petrina A. [5 ]
Messner, Sandra J. [4 ]
Eisen, Andrea [1 ,4 ]
Plewes, Donald B. [2 ,6 ]
Narod, Steven A. [7 ]
Zhang, Liying [3 ]
Yaffe, Martin J. [2 ,6 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Div Med Oncol, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Div Imaging Res, Toronto, ON M4N 3M5, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Clin Trials & Epidemiol, Toronto, ON M4N 3M5, Canada
[4] Sunnybrook Hlth Sci Ctr, Div Prevent Oncol, Toronto, ON M4N 3M5, Canada
[5] Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON M4N 3M5, Canada
[6] Sunnybrook Hlth Sci Ctr, Dept Med Biophys, Toronto, ON M4N 3M5, Canada
[7] Univ Toronto, Womens Coll Hosp, Ctr Res Womens Hlth, Toronto, ON, Canada
关键词
D O I
10.1158/1055-9965.EPI-07-0509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Several observational studies have shown that magnetic resonance imaging (MRI) is significantly more sensitive than mammography for screening women over age 25 at high risk for hereditary breast cancer; however, MRI is more costly and less specific than mammography. We sought to determine the extent to which the low sensitivity of mammography is due to greater breast density. Methods: Breast density was evaluated for all patients on a high-risk screening study who were diagnosed with breast cancer between November 1997 and July 2006. Density was measured in two ways: qualitatively using the four categories characterized by the Breast Imaging Reporting and Data System and quantitatively using a computer-aided technique and classified as (a) <= 10%, (b) 11% to 25%, (c) 26% to 50%, and (d) >50% density. Comparison of sensitivity of mammography (and MRI) for each individual density category and after combining the highest two and lowest two density categories was done using Fisher's exact test. Results: A total of 46 breast cancers [15 ductal carcinoma in situ (DCIS) and 31 invasive] were diagnosed in 45 women (42 with BRCA mutations). Mean age was 48.3 (range, 32-68) years. Overall, sensitivity of mammography versus MRI was 20% versus 87% for DCIS and 26% versus 90% for invasive cancer. There was a trend towards greater mammographic sensitivity for invasive cancer in women with fattier breasts compared with those with greater breast density (37-43% versus 8-12%; P = 0.1), but this trend was not seen for DCIS. Conclusion: It is necessary to add MRI to mammography for screening women with BRCA mutations even if their breast density is low.
引用
收藏
页码:706 / 711
页数:6
相关论文
共 23 条
  • [1] [Anonymous], 2003, Breast imaging reporting and data system
  • [2] QUANTITATIVE CLASSIFICATION OF MAMMOGRAPHIC DENSITIES AND BREAST-CANCER RISK - RESULTS FROM THE CANADIAN NATIONAL BREAST SCREENING STUDY
    BOYD, NF
    BYNG, JW
    JONG, RA
    FISHELL, EK
    LITTLE, LE
    MILLER, AB
    LOCKWOOD, GA
    TRITCHLER, DL
    YAFFE, MJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) : 670 - 675
  • [3] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
    Brekelmans, CTM
    Seynaeve, C
    Bartels, CCM
    Tilanus-Linthorst, MMA
    Meijers-Heijboer, EJ
    Crepin, CMG
    van Geel, AN
    Menke, M
    Verhoog, LC
    van den Ouweland, A
    Obdeijn, IM
    Klijn, JGM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 924 - 930
  • [4] THE QUANTITATIVE-ANALYSIS OF MAMMOGRAPHIC DENSITIES
    BYNG, JW
    BOYD, NF
    FISHELL, E
    JONG, RA
    YAFFE, MJ
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 1994, 39 (10) : 1629 - 1638
  • [5] Meta-analysis of BRCA1 and BRCA2 penetrance
    Chen, Sining
    Parmigiani, Giovanni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1329 - 1333
  • [6] Influence of computer-aided detection on performance of screening mammography
    Fenton, Joshua J.
    Taplin, Stephen H.
    Carney, Patricia A.
    Abraham, Linn
    Sickles, Edward A.
    D'Orsi, Carl
    Berns, Eric A.
    Cutter, Gary
    Hendrick, R. Edward
    Barlow, William E.
    Elmore, Joann G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) : 1399 - 1409
  • [7] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
    Ford, D
    Easton, DF
    Stratton, M
    Narod, S
    Goldgar, D
    Devilee, P
    Bishop, DT
    Weber, B
    Lenoir, G
    Chang-Claude, J
    Sobol, H
    Teare, MD
    Struewing, J
    Arason, A
    Scherneck, S
    Peto, J
    Rebbeck, TR
    Tonin, P
    Neuhausen, S
    Barkardottir, R
    Eyfjord, J
    Lynch, H
    Ponder, BAJ
    Gayther, SA
    Birch, JM
    Lindblom, A
    Stoppa-Lyonnet, D
    Bignon, Y
    Borg, A
    Hamann, U
    Haites, N
    Scott, RJ
    Maugard, CM
    Vasen, H
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) : 676 - 689
  • [8] The development of interval breast malignancies in patients with BRCA mutations
    Komenaka, IK
    Ditkoff, BA
    Joseph, KA
    Russo, D
    Gorroochurn, P
    Ward, M
    Horowitz, E
    El-Tamer, MB
    Schnabel, FR
    [J]. CANCER, 2004, 100 (10) : 2079 - 2083
  • [9] Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
    Kriege, M
    Brekelmans, CTM
    Boetes, C
    Besnard, PE
    Zonderland, HM
    Obdeijn, IM
    Manoliu, RA
    Kok, T
    Peterse, H
    Tilanus-Linthorst, MMA
    Muller, SH
    Meijer, S
    Oosterwijk, JC
    Beex, LVAM
    Tollenaar, RAEM
    de Koning, HJ
    Rutgers, EJT
    Klijn, JGM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) : 427 - 437
  • [10] Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer
    Kuhl, CK
    Schrading, S
    Leutner, CC
    Morakkabati-Spitz, N
    Wardelmann, E
    Fimmers, R
    Kuhn, W
    Schild, HH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8469 - 8476